Updated Date: Tue, 10 Mar 2026 00:00:00 EDT
Updated Date: Tue, 10 Mar 2026 00:00:00 EDT
Updated Date: Tue, 10 Mar 2026 00:00:00 EDT
Updated Date: Tue, 10 Mar 2026 00:00:00 EDT
Financing and global licensing deal to accelerate phase 2b development of AP306
Collaboration aims to streamline and scale next‑generation Treg therapy production
The recent measles outbreaks across the UK, US, and Europe are more than a series of vaccination failures. […]
Updated Date: Mon, 09 Mar 2026 00:00:00 EDT
Updated Date: Mon, 09 Mar 2026 00:00:00 EDT
A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered […]